Infliximab (Anti-TNF-α)
CAT:
804-HY-P9970A-01
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: Yes

Infliximab (Anti-TNF-α)
- UNSPSC Description: Infliximab (Anti-TNF-α) (Avakine (Anti-TNF-α)) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab (Anti-TNF-α) prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab (Anti-TNF-α) has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research[1][2].
- Target Antigen: TNF Receptor
- Type: Inhibitory Antibodies
- Related Pathways: Apoptosis
- Applications: Metabolism-sugar/lipid metabolism
- Field of Research: Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease
- Assay Protocol: https://www.medchemexpress.com/infliximab-anti-tnf-α.html
- Purity: 99.00
- Smiles: [Infliximab (Anti-TNF-a)]
- References & Citations: [1]Lucia A Méndez-García, et al. Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro. Scand J Immunol. 2018 Nov;88(5):e12716. |[2]Isamu Yamakawa, et al. Inactivation of TNF-α ameliorates diabetic neuropathy in mice. Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E844-52.
- Shipping Conditions: Dry Ice
- Storage Conditions: Store at -80°C for 2 years
- Clinical Information: No Development Reported